Newsroom | Top Stories | Abbott U.S.
WEBJan 19, 2024 · Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
Abbott Laboratories (ABT) Gets a Buy from Wells Fargo
WEB2 days ago · In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $133.00. The company’s shares ...
Abbott MediaRoom - Press Releases
WEBJul 24, 2024 · Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside. Mar 27, 2024.
Abbott Reports Fourth-Quarter and Full-Year 2023 ... - Abbott …
WEBABBOTT PARK, Ill., Jan. 24, 2024 / PRNewswire / -- Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023. Fourth-quarter sales increased 1.5 percent on a reported basis, 2.1 percent on an organic basis, and 11.0 percent on an organic basis, excluding COVID-19 testing-related sales 1.
Abbott’s Q4 Earnings Sustain Momentum Into 2024
WEBJan 24, 2024 · Sales for the fourth quarter of 2023 reached $10.2 billion, an 11.0% organic increase, excluding COVID-19 testing-related revenue, driven by Medical Devices (up 15.4% organic; 17.5% reported) and Nutrition (up 13.9% organic; 12.2% reported).
After baby formula problems, Abbott Laboratories under DOJ ... - NBC News
WEBJan 21, 2023 · Abbott Laboratories is under investigation by the U.S. Department of Justice, the company confirmed Friday, almost a year after it shut down a Michigan baby-formula plant after illnesses were...
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, …
WEBApr 17, 2024 · ABT. Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance. Wednesday, Abbott Laboratories (NYSE: ABT) reported first-quarter sales of $9.96 billion, up...
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat …
WEBJul 18, 2024 · On Thursday, Abbott Laboratories (NYSE:ABT) reported second-quarter sales of $10.38 billion, up 4%, almost in line with the consensus of $10.37 billion.
Abbott Reports Second-Quarter 2023 Results; Increases Outlook …
WEBJul 20, 2023 · Worldwide COVID-19 testing sales were $263 million in the second quarter of 2023 compared to $2.324 billion in the second quarter of the prior year. Excluding COVID-19 testing-related sales, global Diagnostics sales increased 4.3 percent on a reported basis and 7.1 percent on an organic basis.
Abbott Laboratories' Best Segment Just Got Even Better: Is the …
WEB3 days ago · Let's review the details and find out what it all means for investors. Abbott Labs' key product line in its diabetes care segment is the FreeStyle Libre, a portfolio of continuous glucose ...
Skip to content